The Netherlands

International Journal of Technology Assessment in Health Care

Volumn 25, Issue SUPPL.S1, 2009, Pages 143-147

  Banta, David ^a,b   Oortwijn, Wija J ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ECORYS Nederland BV ^*  (France)

^c ECORYS Netherlands   (Netherlands)

Author keywords

Decision making; Health planning; Health technology assessment; History; The Netherlands

Indexed keywords

CHRONIC ILLNESS; EVIDENCE-BASED MEDICINE; HEALTH TECHNOLOGY ASSESSMENTS; HEALTH-CARE SYSTEM; NETHERLANDS; POLICY DECISIONS; POLICY DOCUMENTS;

HEALTH; INSURANCE; PLANNING; TECHNOLOGICAL FORECASTING;

DECISION MAKING;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CONFLICT; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DESCRIPTIVE RESEARCH; DISABILITY; DRUG CONTROL; DRUG INDUSTRY; ECONOMIC EVALUATION; ENVIRONMENTAL PROTECTION; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; FUNDING; GOVERNMENT; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROGRAM; HISTORY; INTERNET; LAW; LEADERSHIP; MEDICAL RESEARCH; MEDICAL SOCIETY; NETHERLANDS; PREVENTIVE MEDICINE; PUBLIC HEALTH; REVIEW; SCREENING;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; NETHERLANDS; ORGANIZATIONAL CASE STUDIES; PROGRAM DEVELOPMENT; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 75149114629     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309090564     Document Type: Review

References (20)

1. Banta HD, Oortwijn W. Health technology assessment and screening in the Netherlands: Case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy. Int J Technol Assess Health Care. 2001;17:369-377.
2. Banta HD, Oortwijn WJ, Van Beekum WT. The organization of health care technology assessment in the Netherlands. The Hague: The Rathenau Institute; 1995.
3. Banta D, Gelijns A, eds. Anticipating and assessing health care technology. vol.1. General considerations and policy conclusions. Dordrecht: Martinus Nijhoff Publishers; 1987.
4. Bos M. Health care technology in the Netherlands. In: Health care technology and its assessment in eight countries. Washington, DC: US Government Printing Office; 1995:171-208.
5. Canadian Coordinating Office for Health Technology Assessment. Guide for economic evaluation of pharmaceuticals. 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 1997.
6. College voor zorgverzekeringen (Health Care Insurance Board). Richtlijnen voor farmacoeconomische onderzoek [Dutch guidelines for pharmacoeconomic research]. Amstelveen: College voor zorgverzekeringen; 1999.
7. DeWolf P, BrouwerWB,Rutten FF. Regulating the Dutch pharmaceutical market: Improving efficiency or controlling costs? Int J Health Plann Manage. 2005;20:351-374.
8. Dunning A. Committee on choices in health care (Kiezen en Delen). Rijswijk: Ministry of Health; 1991.
9. Health Council. Medical practice at the crossroads. The Hague: Health Council; 1996.
10. Health Insurance Council. Assessment of the benefits package regarding pharmaceuticals. Publication 680. Amstelveen: Ziekenfondsraad; 1997.
11. Institute for Medical Technology Assessment (iMTA). The costs and effects of mass screening for breast cancer. Rotterdam: Erasmus University Rotterdam; 1987.
12. Mastenbroek CG, Van Der Meer FM, Zwaap J, Fikken F, Polman MPH. Pakketbeheer in de praktijk. Diemen: College voor zorgverzekeringen; 2006.
13. Ministry of Health. Law on population screening. Rijswijk: Ministry of Health; 1996.
14. Ministry of Health. Prevention. http://www.minvws.nl/en/ themes/prevention/default.asp (accessed September 2008).
15. Ministry of Health. Progress report on medical technology assessment and cost-effectiveness of care. Rijswijk: Ministry of Health, Welfare and Sport; 1997.
16. Ministry of Health. The new care system in the Netherlands (in three languages). http://www.minvws.nl/en/folders/z/ 2006/the-new-health-insurance- system-in-three-languages.asp (accessed September 2008).
17. Oortwijn W, Hanney SH, Ligtvoet A, et al. Assessing the impact of health technology assessment in the Netherlands. Int J Technol Assess Health Care. 2008;4:259-269.
18. Oostenbrink JB, Bouwmans CAM,Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek: Methoden en richtlijnprijzen voor economische evaluatie in de gezondheidszorg [Manual for costing research:Methods and reference prices for economic evaluation in healthcare]. Amstelveen: College voor zorgverzekeringen; 2004.
19. Rigter H. Assessment of health care technology in the Netherlands. In: Banta D, Luce B, eds. Health care technology and its assessment. Oxford: Oxford University Press; 1993:213-222.
20. Toenders WGM. Breedte geneesmiddelenpakket [Breadth of the benefits package regarding pharmaceuticals]. Amstelveen: College voor zorgverzekeringen; 2001.